MPWT
ALXN

MassMutual Private Wealth & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-127
Closed -$23K – 1378
2021
Q2 		$23K Buy
127
+78
+159% +$13.4K ﹤0.01% 561
2021
Q1 		$7K Buy
+49
New +$7.58K ﹤0.01% 671
2018
Q3 		– Sell
-50
Closed -$6.21K – 1142
2018
Q2 		$6.21K Sell
50
-17
-25% -$1.99K ﹤0.01% 683
2018
Q1 		$7.47K Buy
+67
New +$8.01K ﹤0.01% 647
2016
Q1 		– Sell
-35
Closed -$5.14K – 924
2015
Q4 		$6.68K Buy
+35
New +$6.11K ﹤0.01% 533

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

MassMutual Private Wealth & Trust's ALXN Position: Q3 2021 in Review

MassMutual Private Wealth & Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 127 shares — an estimated $23K sold.

MassMutual Private Wealth & Trust first reported a position in ALXN in Q4 2015 and held it in 5 quarters. The position peaked at $23K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • MassMutual Private Wealth & Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 127 Alexion Pharmaceuticals shares in Q3 2021, an estimated $23K.
  • MassMutual Private Wealth & Trust first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 5 quarters.
  • MassMutual Private Wealth & Trust's Alexion Pharmaceuticals position peaked at $23K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2021, filed 12 Nov 2021.